NCT05119816

Brief Summary

Kidney biopsy (KB) is an invasive procedure that is very useful in diagnosing kidney disease in both the native kidney and the transplanted kidney. Patients undergo KB can feel anxiety and pain. Pain is considered one of the worst experiences for patients and anxiety affects the sympathetic nervous system, the endocrine system and the immune system. The aim of this preliminary study was to evaluate the influence of MTI as a complementary/nonpharmacological intervention on heart rate variability, anxiety and pain and promote more compliant behaviours during KB.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

November 4, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

November 15, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 25, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2022

Completed
Last Updated

July 20, 2022

Status Verified

July 1, 2022

Enrollment Period

1.7 years

First QC Date

November 4, 2021

Last Update Submit

July 19, 2022

Conditions

Keywords

music therapyanxietypainheart rate variabilitysatisfation

Outcome Measures

Primary Outcomes (3)

  • State Trait Anxiety Inventory Y-1

    State Trait Anxiety Inventory Y-1(STAI-Y1) was used to measure how the subject felt in that moment. Subjects were asked to rate the intensity of their anxious feelings on 20 items on a four point scale: not at all, somewhat, moderately so, or very much so. STAI-Y values \<40 defined absence of anxiety, between 40 and 50 mild anxiety, 51-60 moderate anxiety, and\> 59 severe anxiety. T0 30 minutes before biopsy

    30 minutes before biopsy

  • State Trait Anxiety Inventory Y-1

    State Trait Anxiety Inventory Y-1(STAI-Y1) was used to measure how the subject felt in that moment. Subjects were asked to rate the intensity of their anxious feelings on 20 items on a four point scale: not at all, somewhat, moderately so, or very much so. STAI-Y values \<40 defined absence of anxiety, between 40 and 50 mild anxiety, 51-60 moderate anxiety, and\> 59 severe anxiety. T1 1 hour after biopsy

    1 hour after biopsy

  • visual analogic scale (VAS)

    A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured.VAS is usually a horizontal line, 100 mm in length, anchored by word descriptors at each end. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks.

    through study completion - 5 minutes after biopsy

Secondary Outcomes (1)

  • heart rate variability

    during biopsy procedure

Study Arms (2)

music therapy group

EXPERIMENTAL

Patients receive an individual intervention of receptive music therapy during biopsy

Other: music therapy intervention

Control group

NO INTERVENTION

Patients receive standard care

Interventions

Received a customize playlists prepared by a certified music therapist to listening to during KB

music therapy group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age over 18 years
  • not severe neurological or psychiatric conditions
  • not hearing impairment

You may not qualify if:

  • age under 18 years
  • severe neurological or psychiatric conditions
  • hearing impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOUConsorziale Policlinico Di Bari

Bari, 70124, Italy

Location

MeSH Terms

Conditions

Kidney DiseasesRenal Insufficiency, ChronicAnxiety DisordersPain

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesRenal InsufficiencyChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsMental DisordersNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

November 4, 2021

First Posted

November 15, 2021

Study Start

June 1, 2020

Primary Completion

January 25, 2022

Study Completion

March 31, 2022

Last Updated

July 20, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations